» Articles » PMID: 20149235

Adherence to and Acceptability of Artemether-lumefantrine As First-line Anti-malarial Treatment: Evidence from a Rural Community in Tanzania

Overview
Journal Malar J
Publisher Biomed Central
Specialty Tropical Medicine
Date 2010 Feb 13
PMID 20149235
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Controlled clinical trials have shown that a six-dose regimen of artemether-lumefantrine (AL) therapy for uncomplicated Plasmodium falciparum malaria results in cure rates >95% with good tolerability.

Materials And Methods: A prospective study was carried out to document the adherence to and acceptability of AL administration. This was undertaken in the context of the ALIVE study, a prospective, community-based, observational study in a rural, malaria-endemic area of Tanzania. Following microscopic confirmation of P. falciparum infection, the first AL dose was taken under supervision, with the subsequent five doses taken unsupervised at home. Patients were randomized to receive a home-based assessment close to the scheduled time for one of the unsupervised doses, but were blinded to which follow-up visit they had been allocated. A structured questionnaire was administered by trained staff and AL consumption was confirmed by inspection of blister packs.

Results: A total of 552 patients were recruited of whom 352 (63.8%) were <13 years old. The randomization process allocated 112, 109, 110, 100 and 111 patients to a follow-up visit after doses 2, 3, 4, 5 and 6, respectively. For dose 2, 92.0% of patients (103/112) correctly took AL at 8 +/- 1 hours after dose 1. The remaining doses were taken within four hours of the correct time in 87-95% of cases. Nine patients (1.7%) missed one dose. Blister packs were available for inspection in 548 of cases (99.3%) and confirmed patient-reported data that the previous dose had been administered. Nearly all patients took AL with water (549/552 [99.5%]). Two patients (0.4%) took the drug with food. The dosing pictogram and clustering of tablets within the blister packs was considered helpful by 91.8% and 100.0% of patients, respectively. Overall, 87.1% of patients (481/552) found AL easier to take/administer than sulphadoxine-pyrimethamine (SP) and 87.7% (484/552) believed that AL was more effective than SP.

Discussion: Factors contributing to adherence were likely to be helpful packaging, pictorial dosing instructions and patients' conviction that AL is effective.

Conclusion: Adherence to the dosing regimen and timing of AL administration was very good.

Citing Articles

Attitudes, practices, and determinants of community care-seeking behaviours for fever/malaria episodes in the context of the implementation of multiple first-line therapies for uncomplicated malaria in the health district of Kaya, Burkina Faso.

Kabore J, Siribie M, Hien D, Soulama I, Barry N, Nombre Y Malar J. 2022; 21(1):155.

PMID: 35637506 PMC: 9153091. DOI: 10.1186/s12936-022-04180-z.


Adherence to Dihydroartemisinin + Piperaquine Treatment Regimen in Low and High Endemic Areas in Indonesia.

Chakim I, Pumpaibool T, Sayono , Fauzi E J Trop Med. 2022; 2022:4317522.

PMID: 35309871 PMC: 8933069. DOI: 10.1155/2022/4317522.


Efficacy of Artemether-Lumefantrine on various and genes isolated in Ghana.

Aninagyei E, Tetteh C, Oppong M, Boye A, Acheampong D Parasite Epidemiol Control. 2020; 11:e00190.

PMID: 33163636 PMC: 7607505. DOI: 10.1016/j.parepi.2020.e00190.


Efficacy of Mobile Phone Short Message Service (SMS) Reminders on Malaria Treatment Adherence and Day 3 Post-Treatment Reviews (SMS-RES-MAL) in Kenya: A Study Protocol.

Talisuna A, Zurovac D, Githinji S, Oburu A, Malinga J, Nyandigisi A J Clin Trials. 2019; 5(2):217.

PMID: 31285980 PMC: 6614027. DOI: 10.4172/2167-0870.1000217.


Challenges and perceptions of implementing mass testing, treatment and tracking in malaria control: a qualitative study in Pakro sub-district of Ghana.

Ndong I, Okyere D, Enos J, Amambua-Ngwa A, Merle C, Nyarko A BMC Public Health. 2019; 19(1):695.

PMID: 31170964 PMC: 6554894. DOI: 10.1186/s12889-019-7037-1.


References
1.
Rowe A, Rowe S, Snow R, Korenromp E, Schellenberg J, Stein C . The burden of malaria mortality among African children in the year 2000. Int J Epidemiol. 2006; 35(3):691-704. PMC: 3672849. DOI: 10.1093/ije/dyl027. View

2.
Roca-Feltrer A, Carneiro I, Schellenberg J . Estimates of the burden of malaria morbidity in Africa in children under the age of 5 years. Trop Med Int Health. 2008; 13(6):771-83. DOI: 10.1111/j.1365-3156.2008.02076.x. View

3.
Faye B, Ndiaye J, Ndiaye D, Dieng Y, Faye O, Gaye O . Efficacy and tolerability of four antimalarial combinations in the treatment of uncomplicated Plasmodium falciparum malaria in Senegal. Malar J. 2007; 6:80. PMC: 1919387. DOI: 10.1186/1475-2875-6-80. View

4.
Falade C, Makanga M, Premji Z, Ortmann C, Stockmeyer M, Ibarra de Palacios P . Efficacy and safety of artemether-lumefantrine (Coartem) tablets (six-dose regimen) in African infants and children with acute, uncomplicated falciparum malaria. Trans R Soc Trop Med Hyg. 2005; 99(6):459-67. DOI: 10.1016/j.trstmh.2004.09.013. View

5.
Ajayi I, Falade C, Olley B, Yusuf B, Gbotosho S, Iyiola T . A qualitative study of the feasibility and community perception on the effectiveness of artemether-lumefantrine use in the context of home management of malaria in south-west Nigeria. BMC Health Serv Res. 2008; 8:119. PMC: 2429909. DOI: 10.1186/1472-6963-8-119. View